title: Frequent-relapsing, steroid-dependent minimal change disease: is rituximab the answer?
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
authors.forename: Fernando C
authors.initials: FC
authors.lastname: Fervenza
authors.forename: Sanjeev
authors.initials: S
authors.lastname: Sethi
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab
keywords: minimal change disease; nephrotic syndrome; relapses; rituximab; steroid